ProCE Banner Series

When Every Second Counts: The Latest Data and Expert Guidance on Antiplatelet Therapy Reversal for Surgical Professionals

This interactive session will explore evidence-based strategies for antiplatelet reversal in cardiothoracic surgery, focusing on balancing bleeding and thrombotic risks. An expert faculty will review current strategies and unmet needs in antiplatelet therapy, the latest approaches and clinical data on antiplatelet reversal agents, and guidance on integrating antiplatelet therapy reversal agents into urgent and emergent surgical settings. Attendees will gain actionable insights to enhance patient safety and surgical outcomes.

This industry symposium will be held in conjunction with the STS Annual Meeting. It is not part of the official STS scientific program.

Continuing Medical Education (CME) credit for this activity is not offered by STS. 

  AMA
Who Should Attend

This educational program is intended for cardiothoracic surgeons, general surgeons, anesthesiologists, oncologists, cardiologists, pulmonologists, radiologists, and other surgical professionals who care for patients on antiplatelet therapy who are experiencing or are at risk of life-threatening bleeding. 

All Events

When Every Second Counts: The Latest Data and Expert Guidance on Antiplatelet Therapy Reversal for Surgical Professionals

Upcoming Events

January

25

2025

6:00 AM - 7:00 AM Pacific Time (PT)

In-personVirtual

Los Angeles Convention Center, 1201 South Figueroa Street, Los Angeles, California 90015

Topics

Antiplatelet Reversal

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge and competence of learners in an effort to optimize treatment for patients with cardiovascular disease. 

Target Audience
This educational program is intended for cardiothoracic surgeons, general surgeons, anesthesiologists, oncologists, cardiologists, pulmonologists, radiologists, and other surgical professionals who care for patients on antiplatelet therapy who are experiencing or are at risk of life-threatening bleeding. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify the mechanistic and pharmacokinetic properties of existing antiplatelet medications
  • Recognize deficiencies in bleeding management for patients undergoing antiplatelet therapy
  • Interpret the latest clinical research on current and new antiplatelet therapy reversal agents to ensure their timely and appropriate use in urgent and emergent surgical settings

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by an educational grant from SERB Pharmaceuticals.